Scott E Szafranski Selected Research

D2C7-(scdsFv)-PE38KDEL

4/2017	Production and quality control assessment of a GLP-grade immunotoxin, D2C7-(scdsFv)-PE38KDEL, for a phase I/II clinical trial.
9/2013	Construction of an immunotoxin, D2C7-(scdsFv)-PE38KDEL, targeting EGFRwt and EGFRvIII for brain tumor therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Scott E Szafranski Research Topics

Disease

4	Neoplasms (Cancer) 01/2018 - 09/2010
4	Glioblastoma (Glioblastoma Multiforme) 04/2017 - 09/2010
3	Glioma (Gliomas) 01/2018 - 09/2010
3	Brain Neoplasms (Brain Tumor) 09/2013 - 09/2010
1	Infertility (Sterility) 04/2017
1	Medulloblastoma 05/2013

Drug/Important Bio-Agent (IBA)

3	epidermal growth factor receptor VIIIIBA 01/2018 - 09/2013
3	Immunotoxins (Immunotoxin)IBA 04/2017 - 05/2013
2	ErbB Receptors (EGF Receptor)IBA 04/2017 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 04/2017 - 09/2013
2	D2C7-(scdsFv)-PE38KDELIBA 04/2017 - 09/2013
1	Pharmaceutical PreparationsIBA 01/2018
1	Single-Chain AntibodiesIBA 01/2018
1	Sodium Dodecyl Sulfate (Sodium Lauryl Sulfate)IBA 04/2017
1	polyacrylamideIBA 04/2017
1	ExotoxinsIBA 04/2017
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2013
1	AntigensIBA 09/2010

Therapy/Procedure

3	Therapeutics 01/2018 - 09/2010
1	Immunotherapy 09/2010